Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.
April 2023 in “Dohuk medical journal” Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.
4 citations
,
July 2023 in “Frontiers in Microbiology” HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.
January 1994 in “JAPANESE JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS” Testosterone and fleece-flower root affect mouse hair growth.
July 2025 in “Clinical Medicine” Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.
February 2020 in “Definitions”
January 1997 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not available for analysis.
January 2026 in “Bandung Conference Series Medical Science” Wearing a hijab does not cause hair loss.
January 2014 in “Springer eBooks” The document's conclusion cannot be determined from the provided text.
November 2022 in “Zenodo (CERN European Organization for Nuclear Research)”
July 2011 in “Oxford University Press eBooks” The document's conclusion cannot be determined without content to analyze.
1 citations
,
April 2024 in “Piel” Telogen effluvium causes sudden hair loss, often due to stress or changes, and is treated by addressing the cause and offering support.
208 citations
,
November 2000 in “Development” Edar and Eda proteins are crucial for proper tooth development.
August 2018 in “Journal of Investigative Dermatology” Tofacitinib may help regrow hair in alopecia areata patients.
10 citations
,
February 2017 in “European journal of neuroscience/EJN. European journal of neuroscience” The availability of certain hormones and specific stimulation patterns affect long-term synaptic changes in the male rat brain.
2 citations
,
January 2022 in “Hair transplant forum international” The FUE-LE technique combines two hair transplant methods to harvest more hair with minimal visible scarring, especially for patients with advanced hair loss.
13 citations
,
February 2007 in “British Journal of Dermatology” EF and PXE not closely related.
Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.
January 2025 in “International Journal of Pharmaceutics” The treatment showed significant hair regrowth in alopecia areata patients without side effects.
December 2005 in “Journal of Marine Fisheries” Telogen effluvium causes temporary hair loss, often triggered by stress or health issues, with hair usually regrowing over time.
December 2005 in “Journal of Marine Fisheries” Telogen effluvium causes temporary hair loss, often triggered by stress or health issues, with hair usually regrowing over time.
1 citations
,
January 1987 in “Veterinary Dermatology” Topical 0.1% tacrolimus improved a rare ear condition in cats.
3 citations
,
August 2021 in “Research Square (Research Square)” The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.
March 2015 in “Daehan boncho haghoeji/Daehan bonchohak hoeji” Haeae-tang helps hair grow in mice.
July 1999 in “Journal of the American Academy of Dermatology”
January 2016 in “Hair transplant forum international” The document corrects the definitions of terms related to FUE, a hair transplant technique.
March 2023 in “PARIPEX INDIAN JOURNAL OF RESEARCH” Tofacitinib helped regrow hair in most patients with severe hair loss.
7 citations
,
March 2021 in “Journal of the American Academy of Dermatology” Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.
August 2016 in “Journal of Investigative Dermatology”